[Table/Fig-7]:
15th Day | 30th Day | |||||||
---|---|---|---|---|---|---|---|---|
Parameter | Base line mean (SD) | Mean (SD) | Change from baseline | p | Mean (SD) | Change from baseline | p | %reduction |
Probing Depth | ||||||||
Group (B) SRP | 6.85±1.18 (100%) | 5±0.86 (73%) | 1.8 | <0.01 | 3.4±1.10 (50%) | 3.4 | <0.01 | 50 |
SRP + Dox (A) | 6.5±1.05 (100%) | 4.1±1.02 (63%) | 2.4 | <0.01 | 2.1±0.97 (32%) | 4.4 | <0.01 | 68 |
Plaque Index | ||||||||
SRP (B) | 2.4± 0.31 (100%) | 1.15± 0.33 (47%) | 1.25 | <0.01 | 0.7±0.47 (29%) | 1.7 | <0.01 | 71 |
SRP + Dox (A) | 2.263± 0.42 (100%) | 0.88±.28 (38%) | 1.38 | <0.01 | 0.34± 0.31 (15%) | 1.92 | <0.01 | 85 |
Gingival Index | ||||||||
SRP (B) | 2.63±.28 (100%) | 1.31±.038 (49%) | 1.32 | <0.01 | 0.78±0.45 (29%) | 1.85 | <0.01 | 71 |
SRP + Dox (A) | 2.51±0.18 (100%) | 0.63±0.30 (25%) | 1.88 | <0.01 | 0.26±0.24 (10%) | 2.25 | <0.01 | 90 |
Paired “t” test: p < 0.05 is significant. Group A: treatment mode SRP +DOX. Group B: treatment mode SRP. Clinical parameters showed significant results in Group A (SRP +DOX). In Group A-Probing depth reduction, Plaque Index and Gingival index reduction was 68%, 85% and 90% respectively, which was significant than Group B- Probing depth reduction, Plaque Index and Gingival index reduction was 50%, 71% and 71% respectively.